TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Medibank Private ( (AU:MPL) ).
Medibank Private Limited successfully held its 2025 Annual General Meeting, where all resolutions from 2 to 7 were passed as ordinary resolutions by poll. The re-election of directors Kathryn Fagg AC and Peter Everingham, along with the election of Dr. Lisa McIntyre and Jacqueline Hey, were approved, reflecting strong shareholder support. Additionally, the adoption of the remuneration report and the grant of performance rights to the CEO were also sanctioned, indicating confidence in the company’s leadership and strategic direction.
The most recent analyst rating on (AU:MPL) stock is a Buy with a A$5.84 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is a prominent player in the health insurance industry, offering a range of health insurance products and services primarily focused on the Australian market.
Average Trading Volume: 5,669,628
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$13.38B
For a thorough assessment of MPL stock, go to TipRanks’ Stock Analysis page.